MedCity News
JANUARY 27, 2025
The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question? The post DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video) appeared first on MedCity News.
PharmaVoice
JANUARY 27, 2025
Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JANUARY 27, 2025
What if these two worlds werent at odds? What if they were two parts of the same story, waiting to be brought together for the benefit of all? The post Bridging the Gap Between Herbal Wisdom and Scientific Research appeared first on MedCity News.
PharmaVoice
JANUARY 27, 2025
These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
JANUARY 27, 2025
Through its partnership with Pelago, Lanterns clients can access Pelagos substance use disorder treatment through Lanterns specialty care platform. The post Lantern Teams Up with Pelago to Expand Access to Substance Use Disorder Treatment appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
JANUARY 27, 2025
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
pharmaphorum
JANUARY 27, 2025
Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.
PharmaTimes
JANUARY 27, 2025
Study highlights VE303's potential in reducing recurrent CDI
pharmaphorum
JANUARY 27, 2025
China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
PharmaTimes
JANUARY 27, 2025
Comparison shows improved survival rates for pancreatic cancer treatment
pharmaphorum
JANUARY 27, 2025
UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.
PharmaTech
JANUARY 27, 2025
Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new Medicare drug price negotiations, and more.
Pharmaceutical Technology
JANUARY 27, 2025
With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
JANUARY 27, 2025
Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.
Pharmaceutical Technology
JANUARY 27, 2025
Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.
PharmaTech
JANUARY 27, 2025
One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial.
Pharmaceutical Commerce
JANUARY 27, 2025
Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Technology
JANUARY 27, 2025
If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.
Pharmacy Times
JANUARY 27, 2025
Administered every 4 weeks, the approval could serve as a breakthrough for easier and more effective care for patients with early Alzheimer disease.
Pharmaceutical Technology
JANUARY 27, 2025
The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of Alzheimer's.
PharmExec
JANUARY 27, 2025
Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmaceutical Technology
JANUARY 27, 2025
The UK biotech sector raised 3.5bn in 2024, the highest annual total since 2021 when 4.5bn was raised.
PharmExec
JANUARY 27, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
JANUARY 27, 2025
Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North Carolina site.
PharmExec
JANUARY 27, 2025
Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with Alzheimer disease administered Leqembi.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
Pharmaceutical Commerce
JANUARY 27, 2025
In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, shares the elements that manufacturers should consider when selecting a 3PL.
PharmExec
JANUARY 27, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
JANUARY 27, 2025
The latest news for pharma industry insiders.
Expert insights. Personalized for you.
285 
Let's personalize your content